Jasper Hellweg
Stock Analyst at Argus Research
(2.09)
# 2,953
Out of 5,116 analysts
91
Total ratings
47.89%
Success rate
3.61%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Downgrades: Hold | n/a | $19.38 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $126.23 | +50.52% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $177.08 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $507.16 | -21.13% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $134.95 | +11.15% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $48.47 | +23.79% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $784.97 | +49.05% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $462.90 | +18.82% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $92.90 | -8.50% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $52.40 | +138.55% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $31.20 | +348.72% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $229.98 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $31.89 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $226.92 | +27.80% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $78.88 | +26.77% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $253.89 | +16.19% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $12.43 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $175.94 | -23.27% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $13.82 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $222.06 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $195.83 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $29.83 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $477.13 | -67.51% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $67.50 | +33.33% | 1 | Sep 19, 2018 |
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $19.38
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $126.23
Upside: +50.52%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $177.08
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $507.16
Upside: -21.13%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $134.95
Upside: +11.15%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $48.47
Upside: +23.79%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $784.97
Upside: +49.05%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $462.90
Upside: +18.82%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $92.90
Upside: -8.50%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $52.40
Upside: +138.55%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $31.20
Upside: +348.72%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $229.98
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $31.89
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $226.92
Upside: +27.80%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $78.88
Upside: +26.77%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $253.89
Upside: +16.19%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $12.43
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $175.94
Upside: -23.27%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $13.82
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $222.06
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $195.83
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $29.83
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $477.13
Upside: -67.51%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $67.50
Upside: +33.33%